Magnetic resonance diagnostic markers in clinically sporadic prion disease: A combined brain magnetic resonance imaging and spectroscopy study

Brain

Volumn 132, Issue 10, 2009, Pages 2669-2679

  Lodi, Raffaele ^a   Parchi, Piero ^a   Tonon, Caterina ^a   Manners, David ^a   Capellari, Sabina ^a   Strammiello, Rosaria ^a   Rinaldi, Rita ^b   Testa, Claudia ^a   Malucelli, Emil ^a   Mostacci, Barbara ^a   Rizzo, Giovanni ^a   Pierangeli, Giulia ^a   Cortelli, Pietro ^a   Montagna, Pasquale ^a   Barbiroli, Bruno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Diffusion weighted imaging; Magnetic resonance; Prion diseases; Proton MR spectroscopy

Indexed keywords

CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRION DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WESTERN BLOTTING;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; BRAIN CHEMISTRY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PRION DISEASES; PRIONS;

EID: 70349941101     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp210     Document Type: Article

References (37)

1. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. 4th edn. London: Blackwell; 2002.
2. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999; 56: 577-583
3. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298
4. Bruhn H, Weber T, Thorwirth V, Frahm J. In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 1991; 337: 1610-1611
5. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001; 56: 1528-1533
6. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-442
7. Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001; 56: 726-739
8. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-2287
9. Cordery RJ, MacManus D, Godbolt A, Rossor MN, Waldman AD. Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 2006; 16: 1692-1698
10. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127: 21-33.
11. Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, et al. The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. Magn Reson Imaging 2006; 24: 1121-1129
12. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. 1: Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66: 213-239
13. Graham GD, Petroff OA, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW. Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 1993; 43: 2065-2068
14. Haïk S, Galanaud D, Linguraru MG, Peoc?h K, Privat N, Faucheux BA, et al. In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 2008; 65: 545-549
15. Heinemann U, Krasnianski A, Meissner B, Gloeckner SF, Kretzschmar HA, Zerr I. Molecular subtype-specific clinical diagnosis of prion diseases. Vet Microbiol 2007; 123: 328-335
16. Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, Poser S, Meissner B, Tschampa HJ, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. Am J Neuroradiol 2006; 27: 1459-1462
17. Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 2008; 248: 210-220
18. Krasnianski A, Bartl M, Sanchez Juan PJ, Heinemann U, Meissner B, Varges D, et al. Fatal familial insomnia: clinical features and early identification. Ann Neurol 2008; 63: 658-661
19. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006; 129: 2288-2296
20. Lim CC, Tan K, Verma KK, Yin H, Venketasubramanian N. Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. Magn Reson Imaging 2004; 22: 625-629
21. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jä ger HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 2007; 78: 664-670
22. Manners DN, Parchi P, Tonon C, Capellari S, Strammiello R, Testa C, et al. Pathological correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology 2009; 72: 1425-1431
23. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol 2003; 2: 167-176
24. Pandya HG, Coley SC, Wilkinson ID, Griffiths PD. Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 2003; 58: 148-153
25. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233
26. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679
27. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006; 67: 637-643
28. Schrö ter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000; 57: 1751-1757
29. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-449
30. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004; 56: 702-708
31. Tschampa HJ, Mü rtz P, Flacke S, Paus S, Schild HH, Urbach H. Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2003; 24: 908-915
32. Tschampa HJ, Zerr I, Urbach H. Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 2007; 17: 1200-1211
33. Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128: 2026-2033
34. Waldman AD, Cordery RJ, MacManus DG, Godbolt A, Collinge J, Rossor MN. Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. Neuroradiology 2006; 48: 428-433
35. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 2005; 26: 1551-1562
36. Zeidler M, Gibbs CJ Jr, Meslin F. WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease. Geneva: World Health Organization; 1998. p. 47-51.
37. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-815